Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc.

Bullboard Posts

Comment by ChaseYourDreamon Dec 09, 2016 12:20pm

87 Views

Post# 25576810

RE:RE:RE:RE:Today will be a good test

Amen.

Macer said,

if one thing is clear to me after reading this board for years, the market does not understand the clinical side of things, it only reacts to headlines (speaking of venture plays only)

Macer wrote: Very positive news imho.
I could care less how the stock reacts today. The market is still disappointented in TLT's timelines and the recent PP's and today hearing that screening will take 2 more weeks. Rubish, if one thing is clear to me after reading this board for years, the market does not understand the clinical side of things, it only reacts to headlines (speaking of venture plays only)
We are now in phase 1b CLINICAL trials and will be treating patients with this novel compound. I can tell you that there are least 3 people that are not dissappointed that the trial is finally underway.
Two weeks to screen people is necessary because they need to be screened to make sure the cancer has not progressed beyond NIMBC, they also need to be screened for comorbidities that could potential contaminate the data collected from these first three patients.
Sounds like they can treat all three patients in parallel as opposed to successively which is wonderful.
Looking forward to hearing info from the AGM and updated presentations from the clincal team and researchers.

Macer

LaserStock29 wrote: This would be the definition of a calm before storm Last day of tax loss selling 23rd Last day of resp and tfsa contrib dec 30th So when roger says 2 weeks. Im taking it as code for. Dont expect any run until this time. With any luck all 3 are registered and can be treated end 2016. Just deducting some observations.

wasagastar wrote: These clever turkeys just keep on reinventing their handle to softly bash the stock. Looks like this is a very valuable company if so much effort has been put into supressing the stock....at least crazy's persona hasn't shown up yet. Gone for the day - hoping we hear an update by tonight from the AGM. Good luck everyone.